RankingsPricing
  1. US-listed companies
  2. CASSAVA SCIENCES INC

CASSAVA SCIENCES INCSAVA

Market cap
$1.2B
P/E ratio
Back to summarized table
Income statementBalance sheetCash flow
Dec 31,
2011		Dec 31,
2012		Dec 31,
2013		Dec 31,
2014		Dec 31,
2015		Dec 31,
2016		Dec 31,
2017		Dec 31,
2018		Dec 31,
2019		Dec 31,
2020		Dec 31,
2021		Dec 31,
2022		Dec 31,
2023
Net loss-3-332-12-14-15-12-7-5-6-32-76-97
Net loss-3-332-12-14-15-12-7-5-6-32-76-97
Stock-based compensation5734343211225
Stock-based compensation5734343211225
Depreciation----------0804,0001
Depreciation----------0804,0001
Amortization of intangible assets----------0497,0000
Amortization of Intangible Assets----------0497,0000
Gain on sale of property and equipment---------0---
Prepaid and other assets----------11-1-2
Prepaid and other assets----------11-1-2
Operating lease right-of-use assets and liabilities---------0-000
Operating lease right-of-use assets and liabilities---------0-000
us-gaap_IncreaseDecreaseInAccountsPayable-1-00-01-10-0006-37
us-gaap_IncreaseDecreaseInAccountsPayable-1-00-01-10-0006-37
Accrued development expense------------1
Accrued development expense10-0-11-10-01-02-1-
Accrued compensation and benefits-1-0-0-0-0-0-0-0-002-20
Accrued compensation and benefits-1-0-0-0-0-0-0-0-002-20
Other liabilities-------------0
Other liabilities--------001-0-
Net cash used in operating activities-0-7-----8-5-3-5-30-78-82
Net cash used in operating activities-0-7-----8-5-3-5-30-78-82
Stock-based compensation5734343211225
Stock-based compensation5734343211225
Depreciation----------0804,0001
Depreciation----------0804,0001
Amortization of intangible assets----------0497,0000
Amortization of Intangible Assets----------0497,0000
Gain on sale of property and equipment---------0---
Prepaid and other assets----------11-1-2
Prepaid and other assets----------11-1-2
Operating lease right-of-use assets and liabilities---------0-000
Operating lease right-of-use assets and liabilities---------0-000
us-gaap_IncreaseDecreaseInAccountsPayable-1-00-01-10-0006-37
us-gaap_IncreaseDecreaseInAccountsPayable-1-00-01-10-0006-37
Accrued development expense------------1
Accrued development expense10-0-11-10-01-02-1-
Accrued compensation and benefits-1-0-0-0-0-0-0-0-002-20
Accrued compensation and benefits-1-0-0-0-0-0-0-0-002-20
Other liabilities-------------0
Other liabilities--------001-0-
Net cash used in operating activities-0-7-----8-5-3-5-30-78-82
Purchase of property and equipment---000--0-2230
Net cash used in investing activities6018----2--00-22-3-0
Proceeds from issuance of common stock upon exercise of stock options---------0203
Proceeds from issuance of common stock upon exercise of stock options---------0203
Proceeds from issuance of common stock upon exercise of 2018 warrants--------651--
Proceeds from Warrant Exercises--------651--
Proceeds from common stock offering, net of issuance costs9-010---14--19047-
Proceeds from common stock offering, net of issuance costs9-010---14--19047-
Net cash provided by financing activities9-34-----14675192483
Net cash provided by financing activities9-34-----14675192483
Net (decrease) increase in cash and cash equivalents--------370140-32-80
Purchases of property and equipment included in accounts payable-----------0-
Net loss-3-332-12-14-15-12-7-5-6-32-76-97
Net loss-3-332-12-14-15-12-7-5-6-32-76-97
Stock-based compensation5734343211225
Stock-based compensation5734343211225
Depreciation----------0804,0001
Depreciation----------0804,0001
Amortization of intangible assets----------0497,0000
Amortization of Intangible Assets----------0497,0000
Gain on sale of property and equipment---------0---
Prepaid and other assets----------11-1-2
Prepaid and other assets----------11-1-2
Operating lease right-of-use assets and liabilities---------0-000
Operating lease right-of-use assets and liabilities---------0-000
us-gaap_IncreaseDecreaseInAccountsPayable-1-00-01-10-0006-37
us-gaap_IncreaseDecreaseInAccountsPayable-1-00-01-10-0006-37
Accrued development expense------------1
Accrued development expense10-0-11-10-01-02-1-
Accrued compensation and benefits-1-0-0-0-0-0-0-0-002-20
Accrued compensation and benefits-1-0-0-0-0-0-0-0-002-20
Other liabilities-------------0
Other liabilities--------001-0-
Net cash used in operating activities-0-7-----8-5-3-5-30-78-82
Net cash used in operating activities-0-7-----8-5-3-5-30-78-82
Purchase of property and equipment---000--0-2230
Proceeds from sale of property and equipment---------0---
Net cash used in investing activities6018----2--00-22-3-0
Proceeds from issuance of common stock upon exercise of stock options---------0203
Proceeds from issuance of common stock upon exercise of stock options---------0203
Proceeds from issuance of common stock upon exercise of 2018 warrants--------651--
Proceeds from Warrant Exercises--------651--
Proceeds from common stock offering, net of issuance costs9-010---14--19047-
Proceeds from common stock offering, net of issuance costs9-010---14--19047-
Net cash provided by financing activities9-34-----14675192483
Net cash provided by financing activities9-34-----14675192483
Net (decrease) increase in cash and cash equivalents--------370140-32-80
Net (decrease) increase in cash and cash equivalents--------370140-32-80
Purchases of property and equipment included in accounts payable-----------0-